PolyU has developed novel photocrosslinkable nanocomposite bone graft to mimic the natural bone. The low temperature and organic solvent-free fabrication process allows it to encapsulate bioactive molecules for long-term release. It can activate cell signaling pathways to simultaneously promote osteogenesis and angiogenesis while providing optimal mechanical support to the injured area, expediting the healing process. This technology has been commercialised through PolyU academic-led start-up Bonejoy Limited.
To balance the processability, mechanical strength and bioactivity of bone graft materials, PolyU has developed photocrosslinkable nanocomposite bone graft as an affordable and effective alternative to the growing market and serve patients who are receiving orthopedic surgeries. It has high bone regeneration potential, involves simple and green fabrication processes, and incurs low material costs.
With over 80 years of proud tradition and ranking among the world’s top 100 institutions, The Hong Kong Polytechnic University (PolyU) aspires to be a leading university with world-class research and education.
PolyU is a home for educating thinkers, discoverers, innovators and communicators in delivering positive impact. We are committed to nurturing tomorrow’s leaders today, through a holistic education that provides graduates unrivaled placements to thrive in communities, industries and businesses.